Background: Human T cell leukemia virus type 2 (HTLV-2) encodes a viral transactivator Tax. Results: HTLV-2 Tax efficiently immortalizes human memory T lymphocytes with distinct T cell subtypes. Conclusion: HTLV-2 Tax connects IκB kinase complex to autophagy pathways for promoting T cell survival and proliferation. Significance: Learning the oncogenic potential of HTLV-2 Tax is critical for understanding HTLV-2 pathogenesis.
retrovirus, termed HTLV-2, is not currently linked to leukemia induction, though the viral genome was detected in some cases of hairy cell leukemia (5) . Thus, HTLV-2 may lack certain abilities to transform virally infected T cells into malignant ones.
HTLV-1 and -2 share strikingly similar structures of the viral genomes and both viruses encode highly homologous transforming proteins, Tax (6, 7) . One of the oncogenic properties of Tax1 (HTLV-1 Tax) is the induction of persistent activation of NF-κB in host cells by stimulating both canonical and noncanonical pathways of NF-κB signaling (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Tax2 (HTLV-2 Tax) only activates canonical NF-κB signaling (6, 7) . The role of Tax2 in deregulating other oncogenic signaling pathways is poorly studied. Further, the Tax1 transgenic mice developed ATL-like leukemia (18) , however the oncogenic activity of Tax2 in mouse model has not been reported.
Several studies suggested that Tax2 is less oncogenic than Tax1. Tax2 transformed rat fibroblast cells less efficiently than Tax1 (19) . In addition, the transforming activity of Tax2 on CTLL-2 cell line, an IL-2-dependent murine T cell line, was weaker than Tax1 (20) . Dissecting the protein structures of Tax indicated that although there is 75% amino acid sequence homology shared by both viral proteins, Tax2 lacks the leucine zipper-like region and the C-terminal PDZ binding motif (PBM) on Tax1 (6, 7) . When Tax2 was fused with the PBM motif from Tax1, such chimeric protein induced NF-κB processing and resulted in an equal transforming efficiency to Tax1 in CTLL-2 cells (20) . Intriguingly, both viruses immortalized primary human T cells at a comparable efficiency (6, 7) . It is conceivable that the oncogenic potential of the Tax proteins is best determined in human primary T cells, the natural host cells for HTLV-1 or -2 infection, rather than in rodent cells that are highly susceptible to viral or cellular oncogene-mediated transformation. Indeed, devoid of other viral components, Tax1 appeared to be a weak oncoprotein as Tax1-mediated immortalization of primary human T cells was a rare incidence (21) . The ability of Tax2 in immortalizing human T cells has not been previously reported. In the present study, we evaluated the activity of Tax2 in immortalizing human primary CD4 T cells and established four Tax2-immortalized T cell lines with unique properties of activated memory helper T cells. In addition to the oncogenic activations known in HTLV-1-transformed T cells, our study identified autophagy dysregulation by Tax2 as a novel survival mechanism in Tax2-immortalized T cells.
EXPERIMENTAL PROCEDURES
Lentivirus vector, viral production and transduction of primary CD4 T cells -The tax gene from HTLV-2 was fused with enhanced green fluorescence protein (GFP), and the tax2-gfp fusion fragment was cloned into the lentivirus vector pLCEF8 (22) , in which the human elongation factor 1 alpha promoter drives expression of Tax2-GFP. The procedure for lentiviral production and concentration was described previously (22) . Human peripheral blood lymphocytes were isolated from healthy blood donors, and stimulated with PHA (1µg/ml) for 24 hours, followed by adding recombinant IL-2 (100u/ml) (AIDS Reagent Program). The activated lymphocytes were cultured for 5-7 days, and the CD4+ cells were enriched with anti-CD4 magnetic beads (Invitrogen). These purified CD4 T cells were then transduced with the lentivirus carrying the tax2-gfp expression cassette. The transduced cells were cultured continuously in complete media containing 20% fetal bovine serum and 100u/ml of recombinant IL-2. Lentivirus vector-based shRNAs specific for human Beclin1 were obtained from Open Biosystems, and IKK-specific shRNAs were described previously (22) .
Cell lines, antibodies and chemicals -MT-2 and MoT cell lines were obtained from AIDS Reagent Program (23) , and HT1080 line was from ATCC. Antibodies for pERK1/2, ERK1, pMEK1, MEK1, pAkt1, Akt1 and GST were purchased from Santa Cruz Biotechnology, and anti-Bcl-2, Bcl-xL, Mcl-1, pSTAT3, were from Cell Signaling. U0126, wortmanin, LY294002, BAY11-7082, 3-methyladenin, chloroquine and bortezomib were purchased from Sigma.
Immunophenotype analysis, cell proliferation assay and human telomerase reverse transcriptase activity assay -The Immunophenotype of Tax2-immortalized T cell line was determined with FACS. Cells were stained with allophycocyanin (APC) conjugated antibodies including anti-CD3, -CD4, -CD25, -TCRαβ, -CD45RO and -CD69 (eBioscience) according to the manufacturer's instruction. The stained cells were subjected to FACS analysis. For IFNγ intracellular staining, TX2-1 and TX2-4 cells were incubated in phosphatebuffered saline containing 10µg/ml Brefeldin A (Sigma) for 4h, and were then stained with APCconjugated anti-IFNγ antibody after fixation and permeabilization using the intracellular staining kit from eBioscience, followed by FACS analysis. Cell proliferation assay was performed using tetrazolium compound based CellTiter 96 ® AQueous One Solution Cell Proliferation (MTS) assay (Promega). Telomerase reverse transcriptase activity was measured using TRAPEZE Telomerase Detection Kit (Millipore).
Electrophoretic mobility gel shift assay (EMSA) -Nuclear extracts were prepared from various T cell lines using NE-PER nuclear and cytoplasmic extraction reagents (Pierce). The oligonucleotide was 5'-end labeled with biotin (Integrated DNA Technologies) and annealed to its complementary strand. The binding activities were examined by EMSA using Light Shift Chemiluminescent EMSA Kit (Pierce) following the protocol reported previously (22) . The oligonucleotide probes are for STAT5 (5'-AGATTTCTAGGAATTCAATCC-3'), Oct-1 (5'-TGTCGAATGCAAATCACTAGA A-3'), STAT3 (5'-GATCCTTCTGGGAATTCCT AGATC-3') and NF-κB (5'-GATCCGGCAGGGG AATCTCCCTCTC-3').
Real-time quantitative PCR -Total RNA was isolated using the RNeasy kit (Qiagen) and its concentration was determined using the NanoDrop1000 spectrophotometer (Thermo Scientific). Quality and integrity of total RNA was assessed on 1% formaldehyde-agarose gels. cDNA was synthesized using the Omniscript Reverse Transcriptase Kit (Qiagen) following the manufacturer's recommended protocol. Template samples in triplicate were subjected to real-time qPCR (Stratagene Mx3005P system) using Power SYBR Green (Applied Biosystems). The primer sequences will be provided upon request.
Plasmids, immunoblot, co-immunoprecipitation and GST pulldown -The plasmids for FLAG-BECN1, FLAG-UVRAG, FLAG-PI3KC3, p40phox-GFP and GFP-LC3B were described previously (24) . The co-immunoprecipitation and GST pulldown assays were performed using previously reported protocols (22) .
Fluorescence imaging and autophagy assayTo construct fluorescence protein tagged proteins, mWasabi encoding a monomeric green fluorescent protein, or mKate2 encoding a monomeric far red fluorescent protein, was amplified from pTEC15 or pTEC20 (kindly provided by Lalita Ramakrishnan, Addgene plasmid 30174 or 30179 respectively) and was fused into the N-terminus of BECN1 PCR fragment to generate mWasabi-BECN1 or mKate2-BECN1 respectively, which was cloned in the mammalian expression vector pEF2. The mKate2 PCR fragment was fused to the C-terminus of Tax2 to generate Tax2-mKate2. Transient co-transfection was performed in HT1080 cells using FuGeneHD transfection reagent (Roche), and 48 hours posttransfection, the cells were fixed in 4% formaldehyde-PBS and mounted with DAPI. Fluorescent images were taken using an OLYMPUS IX81 deconvolution microscope and analyzed using SlideBook 5.0 software (Intelligent Imaging Innovations). For immunofluorescence staining, cells were fixed in 4% paraformaldehyde-PBS, blocked in 3% horse serum-PBS, stained with the indicated primary antibodies overnight at 4°C, followed by incubation with fluorescent conjugated secondary antibodies and then mounted with DAPI (Invitrogen).
RESULTS
Tax2 immortalizes human CD4+ memory T cells. Activated human primary lymphocytes grow in vitro typically for up to 4 weeks before reaching cell senescence. Extending growth beyond cell senescence is one of the essential steps towards immortalization and ultimately, oncogenic transformation if additional genetic alteration events occur. To investigate the ability of HTLV-2 Tax in immortalizing mature human CD4+ T cells, we isolated CD4+ T cell species from healthy blood donors, which were enriched using anti-CD4 antibody-coated magnetic beads, followed by lentivirus transduction of the tax2-gfp fusion gene. Roughly 40-60% of primary CD4+ T cells were transduced as evidenced by visualization of green fluorescence. Three weeks following transduction, nearly 100% of the transduced cells emitted green fluorescence signal and exhibited clumpy growth patterns. The growth of the Tax2-GFP-expressing cells was strictly dependent on exogenous IL-2.
The tax2-gfp-transduced cells had a long-term growth potential. In fact, continuous growth of these cells in vitro for more than eighteen months was achieved without losing growth potential, indicating that these cells were immortalized. In contrast, GFP-expressing primary CD4 T cells ceased growth in less than four weeks following transduction. Analysis of the cell surface markers of four Tax2-GFP-expressing CD4+ T cell lines demonstrated a CD3+/CD4+/CD25+/TCRαβ+/CD69+/CD45RO+ immunophenotype ( Fig.1) , indicating that these cells were activated memory T lymphocytes. Unlike HTLV-1-transformed T cells in which TCRαβ and CD3 were down-regulated(25), Tax2-immortalized T cells expressed normal levels of these cell surface molecules.
Tax2-immortalized T cell lines represent unique subsets of helper T cells.
In determining expression patterns of selected genes in Tax2-immortalized T lymphocytes, we performed real-time quantitative PCR analysis. Compared to the normal CD4 T cell populations that were cultured at the identical conditions, we found that Tax2-immortalized T cells had differential gene expression profiles. TX2-3 cells expressed significantly high levels of IL-4, TGFβ1 and FAS, and TX2-4 cells showed high levels of IL-5, IL-15, IFNγ and FAS ( Fig.2A and 2B ). TX2-2 cells produced an extremely high level of IL-10 ( Fig.2B ). IL-13 and IL-2 were undetected or detected at very low levels in all Tax2-immortalized T cell lines ( Fig.2A) , unlike HTLV-1-transformed T cells that expressed IL-13 (26, 27) . Consistent with the results from real-time PCR, the intracellular FACS analysis showed that TX2-4 cells expressed a significantly higher level of IFNγ than TX2-1 cells, though a majority of cell populations from these two cell lines produced IFNγ (Fig.2C) . Because these T cell lines expressed comparable levels of Tax2-GFP (Fig.6C) , the increased levels of cytokines in some T cell lines were unlikely caused by Tax2. Instead, these gene expression profiles implicated Tax2 in selectively immortalizing unique subsets of helper T cells. All Tax2-immortalized T cell lines expressed higher levels of Fas than normal CD4 T cells (Fig.2B) , similarly to HTLV-1-transformed T cells (28) . These Tax2-immortalized T cells also produced PDGFRA, but did not synthesize a detectable amount of its ligand, PDGF-BB (Fig.2B) , suggesting that the autocrine loop of the PDGFRA signaling is not the driving force for promoting proliferation of Tax2-expressing T cells.
Tax2 deregulates oncogenic signaling molecules. We next examined oncogenic activation in Tax2-immortalized T cells. The expression patterns of molecules in T cell receptor signaling were first evaluated. As shown in Fig.3A , Tax2-expressing T cell lines expressed proximal signaling molecules of TCR, including Lck, ZAP70 and LAT. In contrast, Lck and ZAP70 were undetected in HTLV-1-transformed MT-2 T cells. Analysis of the common oncogenic pathways showed that similar to MT-2 cells, the Tax2-immportazlied T cell lines, TX2-1 and TX2-2, exhibited hyper-phosphorylation of MEK1, ERK1/2 and Akt1 (Fig.3B) , implying constitutive activities of these kinases. The activities of the transcriptional factors including STAT3 and NF-κB were detected in both Tax2-expressing T cells and MT-2 cells (Fig.3C) , and the activity of STAT5 was only detected in Tax2-established, IL-2-dependent T cells (Fig.3C) . We next investigated additional pro-survival molecules, the Bcl-2 family proteins. A comparable level of Bcl-xL was expressed in normal CD4 T cells, Tax2-T cells and MT-2 cells (Fig.3D) . The level of Mcl-1 was increased in all Tax-expressing T cell lines (Fig.3D) . Interestingly, unlike MT-2 cells that produced a significantly high level of Bcl-2, TX2-1 and TX2-2 cells expressed almost undetectable level of Bcl-2 (Fig.3D) . The expression of Bax, a pro-apoptotic Bcl-2 family protein, was not altered in Taxexpressing T cells as compared to normal CD4 T cells (Fig.3D) . Expectedly, the tumor suppressor protein p53 was stabilized in Tax-expressing cells (Fig.3D) . Examination of TX2-3 and TX2-4 cells demonstrated constitutive activities of NF-κB, STAT3 and STAT5 (Fig.3E) , similar to that seen in TX2-1 and TX2-2 cells (Fig.3C) . The oncogenic activation in Tax2-immortalized T cell lines was apparently similar to that in HTLV-2-infected MoT cells that exhibited constitutive activities of STAT3 and NF-κB (Fig.3F) . Further, the activity of telomerase reverse transcriptase was well maintained in all four Tax2-immortalized T cell lines after prolonged culture (Fig.3G) .
To determine the role of the oncogenic pathways in Tax2-mediated proliferation of primary T cells, we applied various chemical inhibitors to Tax2-immortalized T cells. As shown in Fig.4A and 4B , U0126, the inhibitor of MEK1, and LY294002, the inhibitor of PI3K, impaired phosphorylation of ERK1/2 and Akt1, respectively. Similarly, wortmanin, an inhibitor of PI3K, was shown to effectively inhibit Akt1 phosphorylation in TX2-1 cells (Fig.4C) . Bortezomib, an FDA-approved proteasome inhibitor, inhibited NF-κB activity in a dose-dependent manner, induced caspase activation as seen with cleaved forms of caspase-3, -7 and PARP and reduced cell viability of the Tax2-immortalized T cells (Fig.4D, 4E and 4F) . The above chemical inhibitors and BAY11-7082, an inhibitor of IκB kinase, negatively affected viability of Tax2-immortalized T cells (Fig.4G) . Together, these results indicate that activation of multiple oncogenic signaling pathways is crucial for Tax2-mediated survival and proliferation of human primary memory T cells.
Tax2 deregulates autophagy to promote survival of the immortalized T cells. Autophagy is a pro-survival cellular process for cells under various stresses such as nutrient deprivation, and has been implicated to play a role in supporting T lymphocyte proliferation (29, 30) . To determine whether autophagy plays an important role for the survival and proliferation of Tax2-immortalized T cells, we analyzed autophagic process in these cells. One of the characteristic features of autophagy is generation of a lipidated form of LC3, LC3-II, which associates with autophagosome. In Tax2-expressing T cells, a significantly high level of LC3-II was detected (Fig.5A) . To determine whether autophagy provides a survival signal to Tax2-immortalized T cells, TX2-1 cells were treated with the autophagy inhibitor chloroquine or 3-methyladenin (3-MA). Both chemicals inhibited growth of TX2-1 cells and induced cleavage of caspase-3/-7 ( Fig.5B and 5C ). Collectively, these results indicate that constitutive autophagy is necessary for promoting survival and proliferation of Tax2-immortalized T cells. PI3K/Akt1 signaling is known to inhibit autophagy by activating mammalian target of rapamycin (mTOR) complex, while the IKK/NF-κB signaling has been linked to starvation-or rapamycin-induced autophagy(31,32). Tax2 was shown to activate both signaling pathways in immortalized T cells (Fig.3) . To evaluate the role of Tax2 in induction of autophagy, we co-transfected Tax2 with GFP-LC3 to examine formation of LC3+ autophagosome foci. In the absence of Tax2, GFP-LC3 was evenly distributed in the transfected cells (Fig.5D ). Co-expression of Tax2 and GFP-LC3 led to formation of GFP-LC3 cytoplasmic foci reminiscent of autophagosomes (Fig.5D) . Similarly, the constitutive active form of IκB kinase beta subunit, IKKβKA, promoted formation of the LC3+ autophagosomes (Fig.5D) . Further, co-transfection of Tax2-mKate2, a far-red fluorescent protein (mKate2) tagged Tax2, and p40phox-GFP induced aggregation of the p40phox (Fig.5E) , which indicated that the activity of PI3K class III (PI3KC3), one of the key mediators of autophagy pathway, was stimulated in Tax2-mediated autophagy.
To determine the role of IKK and Beclin1 (BECN1), an essential autophagy molecule, in Tax2-mediated autophagy, we generated BECN1-and IKKβ-deficient HT1080 cell lines by lentivirus transduction of specific shRNAs (Fig.5F ). As shown in Fig.5G , strong accumulation of LC3-II was readily detected in Tax2-or IKKβKA-transfected cells. However, in BECN1-depleted cells, Tax2 or IKKβKA failed to induce accumulation of LC3-II (Fig.5H) . Similarly, in IKKβ-depleted cells, reduced numbers of LC3+ foci were seen upon Tax2 transfection (Fig.5I) . We further verified these findings in Tax2-immortalized T cells. Depletion of IKKα/β in TX2-1 cells resulted in a significant reduction of LC3-II (Fig.5J ) and reduced cell viability (Fig.5K) . In BECN1-knockdown, TX2-1 cells, LC3-II was also reduced compared to the control cells (Fig.5L ) but such reduction was less prominent than that in the IKKα/β-depleted cells ( Fig.5J and 5L ), suggesting that in addition to BECN1, additional autophagy molecules are possibly involved in Tax2-mediated autophagy. Consistent with this finding, BECN1-knockdown cells showed slight reduction of cell viability than the control cells (data not shown). Together, these results suggest that Tax2 deregulates autophagy by modulating a crosstalk between the IKK complex and the autophagy molecule complex.
Tax2 connects the IKK complex to autophagy pathways. The underlying mechanism of Tax2 induction of autophagy was investigated to determine whether Tax2 physically interacts with key components of autophagy pathways. The autophagy molecule complex, which consists of BECN1, UVRAG and PI3KC3, is essential for assembling autophagosomes (33) . We found that Tax2 interacted with BECN1 and PI3KC3 in cotransfected cells, but did not co-precipitate with UVRAG (Fig.6A) . In addition, Tax2 did not interact directly with other autophagy molecules such as LC3 (Fig.6B) . In Tax2-immortalized T cells, the interaction of Tax2 and BECN1 was also detected by co-immunoprecipitation (Fig.6C) . Next, we applied fluorescence imaging technique to visualize Tax2 interaction with autophagy molecules. BECN1 and PI3KC3 were evenly distributed in the cytoplasm, and IKKγ exhibited a cytoplasmic cluster pattern (Fig.6D) . Tax2 recruited BECN1, PI3KC3 and IKKγ into the cytoplasmic punctate foci (Fig.6E) . These results provided structural evidence that Tax2 connects the IKK complex to the autophagy pathways.
DISCUSSION
Our study demonstrates that Tax2 efficiently immortalizes human primary CD4+ memory T cells. Tax2 promotes survival and aberrant proliferation of primary T cells via several mechanisms. Similar to HTLV-1-transformed T cells, Tax2 constitutively activates oncogenic signaling pathways including IKK/NF-κB, PI3K/Akt1, MAPK/ERK1/2 and STAT3 and induces expression of surviving factors such as Mcl-1. In addition, Tax2 deregulates autophagy by connecting the IKK complex to autophagy pathways. Our data show that the oncogenic activation and dysregulation of autophagy contribute significantly to Tax2 immortalization of human T cells.
In contrast to the previous report showing that Tax1 is a weak oncoprotein and immortalizes mature human T cells poorly(21), we found that Tax2 efficiently immortalizes primary T cells. All tax2-gfp transduced T cells were able to grow for more than three months, and four out of twelve Tax2-GFPestablished T cell lines have maintained growth potential for prolonged time. The differential immortalization abilities mediated by Tax1 and Tax2 remain to be solved. One possibility is a progressive loss of Tax1 expression in the late passages of the immortalized T cells. Unlike ATL leukemia cells in which Tax expression is typically lost, the growth of Tax-established primary T cells requires constitutive production of the Tax protein in order to promote T cell survival and proliferation. The activity of a heterologous viral promoter, such as cytomegalovirus promoter (CMV) that was previously utilized to establish Tax1-immortalized primary T cells (21) , may be deleterious during prolonged cell growth due to a possible promoter silencing (34) . In Tax1-immortalized T cell line WT4, Tax1 was expressed at a much lower level than that in MT-2 cells in p40tax form (21) . MT-2 cells express abundant amount of p68 Env-Tax fusion protein but produce extremely low level of p40Tax (35) . The lower level of p40Tax in WT4 cells indicates that the Tax1 expression is barely maintained in most Tax1-established T cell lines. With use of human elongation factor promoter (hEF) to drive the Tax2 expression in the present study, the expression of Tax2 in the immortalized T cell lines is sustainable for over eighteen months in culture. To draw the conclusion that Tax2 performs better than Tax1 in immortalizing human T cells, the same technical approach must be employed. Nevertheless, our study validated the idea that immortalization of mature human T cells can be efficiently achieved by Tax2.
Our study also identifies autophagy as a novel survival mechanism in Tax2-immortalized T cells. Tax2 induces autophagy to promote T cell survival and proliferation by targeting the autophagy molecule complex containing BECN1 and PI3KC3. The role of autophagy in oncogenesis remains controversial. On one hand, autophagy molecules function as tumor suppressors as mice that lack expression of these genes are prone to tumor development (36, 37) . On the other hand, vast amounts of evidence have shown that autophagy contributes to chemotherapy resistance duo to its cytoprotective function (38, 39) . Although autophagy is a fundamental process for anti-viral defense, viruses have developed strategies to subvert or use autophagy for their own benefit. Autophagic process is necessary for productive replication of some oncogenic viruses. For instance, autophagy is implicated in initiation of hepatitis C virus (HCV) infection (40) . Chloroquine, a chemical inhibitor of autophagy, or depletion of autophagy molecules represses HCV replication (41, 42) . The oncogenic X protein from Hepatitis B Virus (HBV) sensitizes cells to starvation-induced autophagy by increasing BECN1 expression (43) . Further, latent membrane protein 1 (LMP1), an oncogene product from Epstein-Barr virus (EBV), induces early or late stage autophagy depending on its expression levels (44) . Inhibition of autophagy in EBV-infected cells suppresses transforming phenotypes resulting from accumulation of LMP1. Not surprisingly, HTLV-2 Tax also deregulates cellular autophagic process for promoting aberrant proliferation of its host cells.
The underlying mechanism of Tax2 induction of autophagy appears to be related to the crosstalk between NF-κB signaling and autophagy pathways.
Tax2 induces hyper-activation of IKK and NF-κB, and both factors are implicated in induction of autophagy(31,32). NF-κB p65RelA induces autophagy by transcriptional activation of the beclin 1 gene(32). However, NF-κB has also been shown to inhibit autophagy in the context of TNFα-induced cell death (45) . The activation of IKKα or IKKβ induced by TNFα has been implicated in the phosphorylation of tuberous sclerosis complex 1/2 (TSC1/2), resulting in activation of mTOR and inhibition of autophagy (46) . Conversely, autophagic process has a negative impact on the activation of IKK and NF-κB. For instance, autophagy facilitates the degradation of the IKK complex and its upstream activator NF-κB-inducing kinase (NIK), contributing to the inhibition of NF-κB signaling (47) . Further, autophagic process depletes p62 (sequestosome1), an activator of the IKK complex, resulting in a diminished activity of NF-κB (48) . Interestingly, IKK has been implicated to be the key regulator of autophagy induced by starvation or rapamycin stimulation that triggers IKK activation(31). Constitutively active IKKβ or myristoylated IKKγ induces autophagy, while depletion of IKKα or IKKβ prevents autophagy induction, suggesting that the IKK complex is central in connecting upstream NF-κB signaling to autophagy pathway. Our data clearly demonstrate that Tax2 recruits the IKK complex, together with the autophagy molecule complex containing BECN1 and PI3KC3, to form LC3+ autophagosome foci. This is executed by the interaction of Tax2 with the IKK complex, BECN1 and PI3KC3, resulting in an increased activity of PI3KC3 and assembly of autophagosomes. Inhibition of autophagy leads to apoptotic death of Tax2-immortalized T cells, supporting a critical role of Tax2-mediated autophagy in T cell immortalization. The present study provides insights into a possible therapeutic intervention with autophagy inhibitors in managing HTLV-2 infection. A) and (B) . Expression of two sets of selected genes was analyzed using real-time quantitative PCR. Relative expression level of a given gene to GAPDH was plotted. The primer sequences were shown in Table 1 TX2-1 cells were treated with DMSO or bortezomib at 1.25, 2.5, 5, 10 or 20nM. 16 hours following the treatment, the nuclear extracts from these cells were prepared and were used for EMSA using NF-κB probe. Oct-1 was used for nuclear extracts loading control. (E). TX2-1 cells were treated similarly to (D) with DMSO or bortezomib at 1.25, 2.5, 5, 10, 20, 40, 80nM for 16h. The total protein lysates were examined with immunoblot for detecting cleaved forms of caspase-3, -7 and PARP. β-actin was used for protein loading control. (F). TX2-1 cells were treated with bortezomib at indicated doses for 48h, and the cell viability was examined by MTT assay. (G). TX2-1 cells were treated with DMSO, U0126 (10µM), LY294002 (10µM), wortmanin (10µM) or BAY11-7802 (10µM) for 24, 48 or 72 hours. Cell viability was determined with MTT assay. 
